全文获取类型
收费全文 | 3056篇 |
免费 | 206篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 56篇 |
妇产科学 | 92篇 |
基础医学 | 424篇 |
口腔科学 | 26篇 |
临床医学 | 282篇 |
内科学 | 727篇 |
皮肤病学 | 146篇 |
神经病学 | 468篇 |
特种医学 | 59篇 |
外科学 | 273篇 |
综合类 | 5篇 |
一般理论 | 1篇 |
预防医学 | 194篇 |
眼科学 | 33篇 |
药学 | 235篇 |
中国医学 | 7篇 |
肿瘤学 | 237篇 |
出版年
2024年 | 7篇 |
2023年 | 42篇 |
2022年 | 105篇 |
2021年 | 152篇 |
2020年 | 88篇 |
2019年 | 98篇 |
2018年 | 111篇 |
2017年 | 99篇 |
2016年 | 111篇 |
2015年 | 138篇 |
2014年 | 163篇 |
2013年 | 199篇 |
2012年 | 272篇 |
2011年 | 259篇 |
2010年 | 124篇 |
2009年 | 122篇 |
2008年 | 189篇 |
2007年 | 195篇 |
2006年 | 158篇 |
2005年 | 157篇 |
2004年 | 126篇 |
2003年 | 110篇 |
2002年 | 99篇 |
2001年 | 25篇 |
2000年 | 15篇 |
1999年 | 10篇 |
1998年 | 13篇 |
1997年 | 15篇 |
1996年 | 6篇 |
1995年 | 8篇 |
1994年 | 9篇 |
1993年 | 6篇 |
1992年 | 6篇 |
1991年 | 4篇 |
1990年 | 6篇 |
1989年 | 9篇 |
1988年 | 5篇 |
1987年 | 2篇 |
1986年 | 5篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 4篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1974年 | 2篇 |
1962年 | 1篇 |
1956年 | 1篇 |
排序方式: 共有3286条查询结果,搜索用时 15 毫秒
81.
82.
Francesca Fioredda Michaela Calvillo Sonia Bonanomi Tiziana Coliva Fabio Tucci Piero Farruggia Marta Pillon Baldassarre Martire Roberta Ghilardi Ugo Ramenghi Daniela Renga Giuseppe Menna Anna Pusiol Angelica Barone Eleonora Gambineri Giovanni Palazzi Gabriella Casazza Marina Lanciotti Carlo Dufour 《American journal of hematology》2012,87(2):238-243
83.
84.
85.
Maria Sole Chimenti Eleonora Ballanti Carlo Perricone Paola Cipriani Roberto Giacomelli Roberto Perricone 《Autoimmunity reviews》2013,12(5):599-606
Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy associated with psoriasis. Pathogenesis is incompletely understood and pathophysiological role of synovium is just beginning to be elucidated. PsA could be considered an enthesal disease and this hypothesis is the link between mechanical stress (entheses) and immunologically active tissue (synovium). Histologically, PsA is characterized by lining layer hyperplasia, diffuse infiltrate of B, T, macrophages and dendritic cells associated with neutrophils' proliferation and angiogenesis. T cells are present, and oligoclonal T-cell expansions have been demonstrated in both skin and synovium. Histological findings are associated with monocyte-derived cytokines expression, as Myeloid-related protein (S100A8/A9). They play an important role in intracellular functions and cytoskeleton–membrane interactions. S100A8/A9 has a role in the propagation and perpetuation of the inflammatory process in patients with psoriasis and PsA, because of an activated monocyte/macrophage system that involve, distal to the skin, the “enthesal-complex.” Complement system can be considered part of the acute phase response as demonstrated by higher plasma levels of C3 and C4 complement components in PsA patients compared with healthy subjects. These abnormal levels are then reverted by anti-TNF drugs. Evidences of efficacy of anti-TNF are expressed by reduction of vascularity and immune cells in synovial tissue. Therefore, innate response generates high concentrations of inflammatory cytokines which promote effector functions of a variety of tissue cells and sustain the characteristic chronicity of synovitis. The challenge will be the development of molecules affecting the balance between innate and adaptive immunity without affecting beneficial functions of the perfect concert of immunological process. 相似文献
86.
87.
Toldo S Schatz AM Mezzaroma E Chawla R Stallard TW Stallard WC Jahangiri A Van Tassell BW Abbate A 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》2012,26(3):273-276
Purpose
Acute myocardial infarction (AMI) drives an intense inflammatory response that contributes to infarct healing and cardiac remodeling. Recently, different studies have identified a role of interleukin-1 (IL-1) in the development of adverse cardiac remodeling. However, in animal models of AMI IL-1 has been shown to be cardioprotective in preconditioning, raising the question of clinical safety of therapeutic IL-1 blockade for autoinflammatory diseases or for the prevention or the treatment of AMI. In this study we proposed to evaluate the effects of pretreatment with recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) on ischemia reperfusion (I/R) injury to the heart.Methods
RhIL-1Ra was given 4?h or 30?min before the surgical induction of I/R. Left ventricular ejection fraction(LVEF) and infarct size were assessed to determine the effects of the drug pretreatment compared to vehicle treated mice.Results
RhIL-1Ra, given 4?h or 30?min before the onset of the ischemia, showed marked cardioprotection though preservation of the LVEF (no change vs sham operated mice) and the reduction of the infarct size (?40?% vs vehicle-treated mice). No differences were observed between the two groups of rhIL-1Ra treatment.Conclusions
IL-1 blockade therapies using rhIL-1Ra prior the onset of AMI protects the myocardium and preserves cardiac function. 相似文献88.
Daniela Damiani Mario Tiribelli Antonella Geromin Michela Cerno Alessandra Sperotto Eleonora Toffoletti Erica Simeone Angela Michelutti Margherita Cavallin Renato Fanin 《Annals of hematology》2012,91(12):1937-1943
We retrospectively analysed 78 patients with relapsed (n?=?38), primary refractory (n?=?34) or untreated (n?=?6) acute myeloid leukaemia (AML) who underwent allogeneic HSCT at our Institution between 2002 and 2011, to verify outcome and to identify factors that can affect long-term outcome. Myeloablative conditioning regimens were used in 48 patients (24 siblings, 24 matched unrelated donor (MUD)), while 30 patients (18 siblings, 12 MUD) received reduced-intensity conditioning. Acute graft versus host disease (GVHD) developed in 37 (47?%) patients, while chronic GVHD occurred in 19 of the 65 evaluable patients (29?%). With a median follow-up time of 5?years, 13 of 78 patients (17?%) are alive and in complete remission (CR), while 64 have died. Cause of death was disease recurrence in 37 patients (58?%), infection in ten patients (16?%) and GVHD in six (9?%). One-year non-relapse mortality was 35?%. In multivariate analysis, performance status ≥80?% WHO and a full-matched donor were associated with a better outcome: these two variables allowed for risk stratification, identifying three groups with significantly different survival after transplant (P?=?0.0001). Considering post-transplant variables, only CR at recovery and development of cGVHD were correlated with a longer survival. Our data confirm the capacity of allogeneic transplant to prolong survival in a significant proportion of extremely high-risk AML patients. 相似文献
89.